We received the German Industry Innovation Award

Frankfurt, Germany, March 21, 2015 – Distinguished for excellence: Our company has received this year's German Industry Innovation Award in the category of "innovative HR concepts". With this prize the jury recognized the two innovation initiatives, the EMD Serono Innovation Cup and Innospire.

Merck KGaA, Darmstadt, Germany supports schistosomiasis education in Mozambique

In Namaacha, together with German Bundesrat President Volker Bouffier, Executive Board member Kai Beckmann presented to Mozambique’s Deputy Health Minister Dr. Mouzinho Saíde 20,000 brochures aimed at educating children on the causes of the tropical worm disease.

Merck KGaA, Darmstadt, Germany, Finishes Year of Key Strategic Moves with Record Figures

"In 2014 we have laid the foundations for future growth,” said Karl-Ludwig Kley, Chairman of the Executive Board. “The company is transforming into a highly specialized, global technology company with the goal to improve the lives of patients and customers.”

Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

November 17, 2014 – Merck KGaA, Darmstadt, Germany, and Pfizer entered into a global agreement to co-develop and co-commercialize our investigational anti-PD-L1 antibody as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.
As part of the agreement, Merck KGaA, Darmstadt, Germany, will co-promote Pfizer’s Xalkori, a medicine to treat non-small cell lung cancer, in the United States and several other key markets.

 

Media Services for the US and Canada – News starting 2013, Dates & Publications

Latest Press Releases
We received the German Industry Innovation Award
We received the German Industry Innovation Award
We received the German Industry Innovation Award
Frankfurt, Germany, March 21, 2015 – Distinguished for excellence: Our company has received this year's German Industry Innovation Award in the category of "innovative HR concepts". With this prize the jury recognized the two innovation initiatives, the EMD Serono Innovation Cup and Innospire.
 
Merck KGaA, Darmstadt, Germany supports schistosomiasis education in Mozambique
Schistosomiasis education in Mozambique
Merck KGaA, Darmstadt, Germany supports schistosomiasis education in Mozambique
In Namaacha, together with German Bundesrat President Volker Bouffier, Executive Board member Kai Beckmann presented to Mozambique’s Deputy Health Minister Dr. Mouzinho Saíde 20,000 brochures aimed at educating children on the causes of the tropical worm disease.
 
Marcus Kuhnert - Member of the Executive Board
Marcus Kuhnert - Member of the Executive Board
Merck KGaA, Darmstadt, Germany, Places U.S. Bond Amounting to US$ 4.0 Billion
Darmstadt, Germany, March 17, 2015 – Merck KGaA, Darmstadt, Germany, successfully placed a U.S. bond via its U.S. subsidiary EMD Finance LLC. The oversubscribed placement is an important element of the financing of the proposed acquisition of the life science company Sigma-Aldrich, which Merck KGaA, Darmstadt, Germany announced in September 2014.
 
 
top

OUR COMPANY IN THE MEDIA

OUR COMPANY IN THE MEDIA
Read how Merck KGaA, Darmstadt, Germany, and its affiliates are covered by media outlets around the world

DOWNLOAD LIBRARY

Download Library
Download images, Media Kits and other material from our media download library

CALENDAR OF EVENTS

Calendar of Events
Find and register for upcoming events

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany, operate under the umbrella brand EMD.
 

CONTACTS FOR JOURNALIST INQUIRIES

Media Team
POSTAL ADDRESS 
Merck KGaA 
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

GENERAL INQUIRIES

Communications Center
Tel.: +49 6151 72-0
Fax: +49 6151 72-2000
 

ANNUAL REPORT 2014

Financial Report
Merck on Facebook
Merck on Twitter
 
  
Read more on M - The Explorer Magazine

Fighting Cancer with Precision Medicine

A large number of patients who suffer from advanced colorectal cancer benefit from an antibody therapy. In these cases, personalized medicine is the key to optimal therapeutic outcomes.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Social commitment in Rio de Janeiro

Brazil is an up-and-coming country of strong contrasts. A growing middle class is flanked by unimaginable wealth on the one hand and bitter poverty on the other.

Read more on M - The Explorer Magazine